Stay updated on Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial
Sign up to get notified when there's something new on the Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial page.

Latest updates to the Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRecruitment is now closed (no longer looking for participants) on the page. The update also adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and shows the latest revision tag v3.6.0.SummaryDifference0.3%

- Check16 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5 in the page footer. This reflects a minor platform update and does not alter study details or other user-visible content.SummaryDifference0.0%

- Check37 days agoChange DetectedThe platform revision tag has advanced from v3.5.3 to v3.5.4, indicating a new build of the site.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page footer revision was updated from v3.5.2 to v3.5.3, indicating a minor site/record interface version change rather than an update to the clinical study information.SummaryDifference0.0%

- Check66 days agoChange DetectedReplimune, Inc. was added and the revision updated from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check95 days agoChange DetectedHeader shows Revision: v3.5.0, replacing v3.4.3. No study details or user-facing functionality were changed.SummaryDifference0.0%

Stay in the know with updates to Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial page.